Radionuclide imaging of osteomyelitis

Area of Science:

• Nuclear Medicine
• Radiology
• Infectious Disease Imaging

Background:

• Osteomyelitis diagnosis often involves radionuclide procedures.
• Traditional bone scans have limitations in specificity due to conditions like degenerative joint disease or fractures.
• Various radiotracers have been explored to improve diagnostic accuracy.

Purpose of the Study:

• To review the current role and emerging applications of radionuclide imaging in diagnosing osteomyelitis.
• To evaluate the effectiveness of different nuclear medicine techniques, including bone scintigraphy, labeled leukocyte imaging, and positron emission tomography (PET) tracers.
• To highlight the advantages and limitations of each imaging modality for specific osteomyelitis presentations.

Main Methods:

• Review of existing literature on radionuclide procedures for osteomyelitis.
• Analysis of diagnostic performance metrics (sensitivity, specificity) for various imaging agents.
• Comparison of conventional techniques (e.g., bone scintigraphy, Gallium-67) with newer agents (e.g., (18)F-FDG, radiolabeled antibodies, ubiquicidin fragments).

Main Results:

• Bone scintigraphy is useful but less specific in complex cases.
• (18)F-FDG PET/CT demonstrates high sensitivity and specificity, particularly for spinal infections.
• In vitro-labeled leukocyte imaging, often combined with bone marrow imaging, is a key method for non-spinal osteomyelitis.
• Emerging agents like radiolabeled ubiquicidin fragments show potential for differentiating infection from inflammation.

Conclusions:

• Nuclear medicine offers a range of tools for osteomyelitis diagnosis, with (18)F-FDG PET/CT being the current standard for spinal infections.
• The utility of (18)F-FDG in diabetic pedal osteomyelitis and prosthetic joint infections requires further investigation.
• Continued development of targeted radiotracers holds promise for improved accuracy and management of osteomyelitis.